A Study of AV0328 Administered to Healthy Adult Volunteers

Clinical trial NCT02853617 · COMPLETED

Trial details

NCT number: NCT02853617
Sponsor: Alopexx Vaccine, LLC
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

PNAG-expressing Pathogenic Microbes Vaccine

Start date: 2017-03-22
Primary completion: 2018-04-23
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.